SCHEMBL28305428

SCHEMBL28305428

CC(C)c1ccnc2cc(Br)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 1/20 0.46
▸ GAK O14976 3/20 0.43
▸ HTT P42858 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ SLC22A12 Q96S37 3/20 0.39
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NR4A2 P43354 1/20 0.36
▸ EGFR P00533 3/20 0.35
▸ FABP4 P15090 1/20 0.35
▸ NCF1 P14598 1/20 0.35
▸ GABRA1 P14867 1/20 0.34
▸ GABRB1 P18505 1/20 0.34
▸ PLAU P00749 1/20 0.34
▸ EPHB6 O15197 1/20 0.34
▸ RIPK2 O43353 1/20 0.34
▸ STK16 O75716 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ ACVR1 Q04771 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8004155 0.86 SLC22A12 (0.49) GAKHTTCYP1A2CYP2C19SLC22A12
SCHEMBL24363075 0.82 ALK (0.46) ALKGAKHTTCYP1A2CYP2C19
SCHEMBL29632066 0.82 ALK (0.46) ALKGAKHTTCYP1A2CYP2C19
SCHEMBL11967045 0.80 AURKA (0.39) ALKHTTLMNASMN1; SMN2NR4A2
SCHEMBL10330490 0.80 ADRA1A (0.51) LMNASMN1; SMN2NR4A2AAK1MEN1
SCHEMBL22648432 0.79 FERMT2 (0.45) GAKNR4A2AAK1
SCHEMBL24420728 0.79 NR4A2 (0.58) CYP1A2LMNASMN1; SMN2NR4A2MEN1
SCHEMBL15836948 0.76 HTR1A (0.55) GAKCYP1A2LMNAEGFRRIPK2
SCHEMBL24716909 0.76 NR4A2 (0.35) SMN1; SMN2NR4A2
SCHEMBL30390607 0.76 ALK (0.50) ALKGAKHTTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109937201-A HEPATITIS B CORE PROTEIN MODULATORS 组装生物科学股份有限公司 2019-06-25 — — CN disclosed
Send feedback